DE69111311T2 - 2-Tetrahydrofuran-Enantiomerderivate, Zwischenprodukte davon und ihre Herstellung. - Google Patents

2-Tetrahydrofuran-Enantiomerderivate, Zwischenprodukte davon und ihre Herstellung.

Info

Publication number
DE69111311T2
DE69111311T2 DE69111311T DE69111311T DE69111311T2 DE 69111311 T2 DE69111311 T2 DE 69111311T2 DE 69111311 T DE69111311 T DE 69111311T DE 69111311 T DE69111311 T DE 69111311T DE 69111311 T2 DE69111311 T2 DE 69111311T2
Authority
DE
Germany
Prior art keywords
compound
formula
enantiomer
tetrahydrofuran
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69111311T
Other languages
German (de)
English (en)
Other versions
DE69111311D1 (de
Inventor
Heinrich Ch-4123 Allschwil Estermann
William Joseph Mountain Lakes N.J. 07046 Houlihan
Prasad Koteswara Parsippany N.J. 07054 Kapa
Russell Lee Randolph N.J. 07869 Underwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Publication of DE69111311D1 publication Critical patent/DE69111311D1/de
Application granted granted Critical
Publication of DE69111311T2 publication Critical patent/DE69111311T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
DE69111311T 1990-06-19 1991-06-19 2-Tetrahydrofuran-Enantiomerderivate, Zwischenprodukte davon und ihre Herstellung. Expired - Fee Related DE69111311T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54043890A 1990-06-19 1990-06-19
US64739691A 1991-01-29 1991-01-29

Publications (2)

Publication Number Publication Date
DE69111311D1 DE69111311D1 (de) 1995-08-24
DE69111311T2 true DE69111311T2 (de) 1996-03-14

Family

ID=27066435

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69111311T Expired - Fee Related DE69111311T2 (de) 1990-06-19 1991-06-19 2-Tetrahydrofuran-Enantiomerderivate, Zwischenprodukte davon und ihre Herstellung.

Country Status (21)

Country Link
EP (1) EP0462935B1 (enExample)
JP (1) JP2709330B2 (enExample)
KR (1) KR920000772A (enExample)
AT (1) ATE125261T1 (enExample)
AU (2) AU649681B2 (enExample)
CA (1) CA2044786A1 (enExample)
CS (1) CS185191A3 (enExample)
DE (1) DE69111311T2 (enExample)
DK (1) DK0462935T3 (enExample)
ES (1) ES2076502T3 (enExample)
FI (1) FI912964A7 (enExample)
GR (1) GR3017437T3 (enExample)
HK (1) HK111996A (enExample)
HU (1) HU210548B (enExample)
IE (1) IE68417B1 (enExample)
IL (1) IL98524A (enExample)
MY (1) MY107022A (enExample)
NZ (1) NZ238573A (enExample)
PL (1) PL164981B1 (enExample)
PT (1) PT97994B (enExample)
TW (1) TW255897B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208352A (en) * 1992-04-02 1993-05-04 Sandoz Ltd. Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compounds
ATE225982T1 (de) * 1998-07-17 2002-10-15 Fuji Photo Film Co Ltd Photozelle und photoelektrochemische zelle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178261A3 (en) * 1984-10-10 1986-12-30 Sandoz Ag Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts
US4601987A (en) * 1985-02-27 1986-07-22 Massachusetts Institute Of Technology Enzymatic production of optical isomers of 2-halopropionic acids
DE3666435D1 (en) * 1985-08-30 1989-11-23 Sandoz Ag Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals
US4673672A (en) 1985-10-28 1987-06-16 Sandoz Pharmaceuticals Corp. Substituted-[hydroxy(tetrahydro)-5-oxo-(2- and 3-furanyl or 2-thienyl)alkoxyphosphinyloxy]-alkanaminium hydroxide, inner salt oxides
US4868319A (en) * 1987-12-22 1989-09-19 Sandoz Pharm. Corp. Process for the preparation of monoalkylcarbamate group-containing compounds

Also Published As

Publication number Publication date
EP0462935B1 (en) 1995-07-19
HK111996A (en) 1996-07-05
NZ238573A (en) 1993-11-25
DK0462935T3 (da) 1995-11-06
CA2044786A1 (en) 1991-12-20
IL98524A (en) 1995-12-31
PT97994B (pt) 1998-11-30
ATE125261T1 (de) 1995-08-15
TW255897B (enExample) 1995-09-01
GR3017437T3 (en) 1995-12-31
IE68417B1 (en) 1996-06-12
HUT58340A (en) 1992-02-28
FI912964A0 (fi) 1991-06-18
MY107022A (en) 1995-08-30
AU649681B2 (en) 1994-06-02
HU911882D0 (en) 1991-12-30
PT97994A (pt) 1992-03-31
IL98524A0 (en) 1992-07-15
IE912081A1 (en) 1992-01-01
FI912964L (fi) 1991-12-20
PL290719A1 (en) 1992-07-27
JPH04270276A (ja) 1992-09-25
PL164981B1 (pl) 1994-10-31
ES2076502T3 (es) 1995-11-01
DE69111311D1 (de) 1995-08-24
AU677403B2 (en) 1997-04-24
AU7140794A (en) 1994-11-03
EP0462935A1 (en) 1991-12-27
CS185191A3 (en) 1992-01-15
HU210548B (en) 1995-05-29
KR920000772A (ko) 1992-01-29
JP2709330B2 (ja) 1998-02-04
AU7843991A (en) 1992-01-02
FI912964A7 (fi) 1991-12-20

Similar Documents

Publication Publication Date Title
DE60208355T2 (de) 2-amino-propanol derivate
DE69029626T2 (de) Benzo[b]thiophen enthaltende lipoxygenaseinhibierende Verbindungen
DE69920208T2 (de) Verbindungen, die als reversible inhibitoren der carnitin palmitoyltransferase wirsam sind
EP0248062A1 (de) Arzeimittel.
EP0071216B1 (de) 3-Hydroxypyrrolidin-2-on-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel
DE69704057T2 (de) Terphenylverbindungen und sie enthaltende arzneimittel
DE69104948T2 (de) Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69903040T2 (de) Piperazinderivate zur replikationshemmung von menschlichem immundefizienz virus
DE69521122T2 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
DE69111311T2 (de) 2-Tetrahydrofuran-Enantiomerderivate, Zwischenprodukte davon und ihre Herstellung.
DE69402463T2 (de) (7S)-7-(2R)-2-(3-Chlorophenyl)-2-Hydoxyethylamino-5,6,7,8-Tetrahydronaphtalen-2-yloxy Essigsäure, ihre pharmazeutisch akzeptablen Salze, mit Beta-3-adrenergischer agonistischer Aktivität und diese enthaltende pharmazeutische Zusammensetzungen
EP0030632B1 (de) Benzothiazolderivate, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE69423339T2 (de) Epoxycyclohexendionderivat
EP0771813A1 (de) Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
CH630925A5 (de) Verfahren zur herstellung von neuen imidazothiazinen.
DE3854991T2 (de) Cyclische Amine und pharmakologische Verbindungen
DE69208464T2 (de) N-((4,5-dihydroxy- und 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl)carbonyl)aminosäure zur therapie osteoartikulärer leiden
EP0006217B1 (de) Substituierte Aminoalkansäuren, ihre Verwendung und Herstellung und sie enthaltende Arzneimittel
DE60132782T2 (de) Prodrugs zu nmda-rezeptorliganden
EP0723969A1 (de) Phosphonocarbonsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
DE69615845T2 (de) Polycyclische alkaloid-derivate als nmda-rezeptor-antagonisten
DE69300011T2 (de) Diacylglycerol-Nicotinate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69007045T2 (de) Piperidinderivate, Verfahren zur Herstellung sowie diese enthaltende pharmazeutische Präparate.
DE10238257B4 (de) Sorbicillacton A und Sorbicillacton-A-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE69114778T2 (de) Bicyclolactamderivat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee